Ascendis Pharma (Brazil) Price Prediction
| A1SN34 Stock | BRL 48.42 0.00 0.00% |
Oversold Vs Overbought
49
Oversold | Overbought |
Ascendis Pharma AS stock price prediction is an act of determining the future value of Ascendis Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Ascendis Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Ascendis Pharma and does not consider all of the tangible or intangible factors available from Ascendis Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with Ascendis Pharma AS, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Ascendis Pharma based on different types of headlines from major news networks to social media. The Ascendis stock price prediction module provides an analysis of price elasticity to changes in media outlook on Ascendis Pharma over a specific investment horizon. Using Ascendis Pharma hype-based prediction, you can estimate the value of Ascendis Pharma AS from the perspective of Ascendis Pharma response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Ascendis Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Ascendis Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Ascendis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ascendis Pharma after-hype prediction price | BRL 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ascendis |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ascendis Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ascendis Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Ascendis Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ascendis Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ascendis Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ascendis Pharma Estimiated After-Hype Price Volatility
In the context of predicting Ascendis Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ascendis Pharma's historical news coverage. Ascendis Pharma's after-hype downside and upside margins for the prediction period are 0.00 and 1.66, respectively. We have considered Ascendis Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ascendis Pharma is out of control at this time. Analysis and calculation of next after-hype price of Ascendis Pharma AS is based on 3 months time horizon.
Ascendis Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Ascendis Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ascendis Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ascendis Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.15 | 1.66 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
48.42 | 0.00 | 0.00 |
|
Ascendis Pharma Hype Timeline
Ascendis Pharma AS is presently traded for 48.42on Sao Paulo Exchange of Brazil. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Ascendis is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.15%. %. The volatility of related hype on Ascendis Pharma is about 0.0%, with the expected price after the next announcement by competition of 48.42. The company has price-to-book (P/B) ratio of 0.9. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ascendis Pharma AS had not issued any dividends in recent years. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out Ascendis Pharma Basic Forecasting Models to cross-verify your projections.Ascendis Pharma Related Hype Analysis
Having access to credible news sources related to Ascendis Pharma's direct competition is more important than ever and may enhance your ability to predict Ascendis Pharma's future price movements. Getting to know how Ascendis Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ascendis Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CRDA34 | Credit Acceptance | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | 0.00 | 4.86 | |
| A1LG34 | Align Technology | 0.00 | 0 per month | 1.06 | 0.08 | 2.98 | (1.65) | 10.03 | |
| M1NS34 | Monster Beverage | 0.00 | 0 per month | 0.00 | (0.09) | 1.39 | (1.69) | 7.35 | |
| L1YG34 | Lloyds Banking Group | 0.00 | 0 per month | 1.26 | 0.16 | 4.82 | (2.45) | 10.68 | |
| M1UF34 | Mitsubishi UFJ Financial | 0.00 | 0 per month | 1.32 | 0.13 | 2.14 | (2.37) | 11.64 | |
| BMOB3 | Bemobi Mobile Tech | 0.00 | 0 per month | 0.00 | (0.08) | 2.27 | (2.68) | 7.75 | |
| P1YC34 | Paycom Software | 0.00 | 0 per month | 1.36 | (0.01) | 2.28 | (1.84) | 11.17 | |
| P1DT34 | Prudential Financial | 0.00 | 0 per month | 0.81 | 0.07 | 1.81 | (1.01) | 8.75 |
Ascendis Pharma Additional Predictive Modules
Most predictive techniques to examine Ascendis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ascendis using various technical indicators. When you analyze Ascendis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ascendis Pharma Predictive Indicators
The successful prediction of Ascendis Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ascendis Pharma AS, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ascendis Pharma based on analysis of Ascendis Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ascendis Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ascendis Pharma's related companies. Story Coverage note for Ascendis Pharma
The number of cover stories for Ascendis Pharma depends on current market conditions and Ascendis Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ascendis Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ascendis Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Ascendis Pharma Short Properties
Ascendis Pharma's future price predictability will typically decrease when Ascendis Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ascendis Pharma AS often depends not only on the future outlook of the potential Ascendis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ascendis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 56.9 M |
Check out Ascendis Pharma Basic Forecasting Models to cross-verify your projections. Note that the Ascendis Pharma AS information on this page should be used as a complementary analysis to other Ascendis Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |